XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Beginning balance at Dec. 31, 2020 $ 34 $ 244,831 $ (218,973) $ 25,892
Beginning balance (in shares) at Dec. 31, 2020 33,801,045      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 662 0 662
Issuance of restricted stock $ 0 0 0 0
Issuance of restricted stock (in shares) 16,260      
Net (loss) income $ 0 0 (2,418) (2,418)
Ending balance at Mar. 31, 2021 $ 34 245,493 (221,391) 24,136
Ending balance (in shares) at Mar. 31, 2021 33,817,305      
Beginning balance at Dec. 31, 2020 $ 34 244,831 (218,973) 25,892
Beginning balance (in shares) at Dec. 31, 2020 33,801,045      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income       (1,336)
Ending balance at Jun. 30, 2021 $ 34 246,074 (220,309) 25,799
Ending balance (in shares) at Jun. 30, 2021 33,889,239      
Beginning balance at Mar. 31, 2021 $ 34 245,493 (221,391) 24,136
Beginning balance (in shares) at Mar. 31, 2021 33,817,305      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 581 0 581
Issuance of restricted stock $ 0 0 0 0
Issuance of restricted stock (in shares) 71,934      
Net (loss) income $ 0 0 1,082 1,082
Ending balance at Jun. 30, 2021 $ 34 246,074 (220,309) 25,799
Ending balance (in shares) at Jun. 30, 2021 33,889,239      
Beginning balance at Dec. 31, 2021 $ 34 247,059 (221,679) 25,414
Beginning balance (in shares) at Dec. 31, 2021 34,364,679      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 368 0 368
Issuance of common stock for acquisition $ 1 499 0 500
Issuance of common stock for acquisition (in shares) 358,367      
Net (loss) income $ 0 0 (2,502) (2,502)
Ending balance at Mar. 31, 2022 $ 35 247,926 (224,181) 23,780
Ending balance (in shares) at Mar. 31, 2022 34,723,046      
Beginning balance at Dec. 31, 2021 $ 34 247,059 (221,679) 25,414
Beginning balance (in shares) at Dec. 31, 2021 34,364,679      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income       (4,394)
Ending balance at Jun. 30, 2022 $ 35 248,378 (226,073) 22,340
Ending balance (in shares) at Jun. 30, 2022 34,723,046      
Beginning balance at Mar. 31, 2022 $ 35 247,926 (224,181) 23,780
Beginning balance (in shares) at Mar. 31, 2022 34,723,046      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 452 0 452
Net (loss) income 0 0 (1,892) (1,892)
Ending balance at Jun. 30, 2022 $ 35 $ 248,378 $ (226,073) $ 22,340
Ending balance (in shares) at Jun. 30, 2022 34,723,046